Purpose. To construct a scoring system to differentiate malignant liposarcomas from benign lipomas by comparing their clinical and magnetic resonance imaging (MRI) features. Methods. Clinical and MRI features of 33 women and 33 men aged 17 to 83 (mean, 53) years who underwent resection of malignant liposarcomas (n=32) or benign lipomas (n=34) were reviewed. Results. The 5 strongest predictors of liposarcoma were male gender, larger tumour maximum dimension, deep to fascia, thick non-fatty septum or nodule, and internal cystic change. A weighted scoring system was constructed using the 5 strongest predictors as: Z score=10X 1 +X 2 +12X 3 +15X 4 +10X 5 , respectively. A cut-off score of 35 was used; all 32 malignant liposarcomas and 4 of 34 benign lipomas scored >35. The cut-off score of ≤35 could predict 30 of 66 lipomatous tumours as benign with a negative predictive value of 100% (p<0.0001). were identified to construct a scoring system to differentiate malignant from benign lipomatous tumours. Further validation in independent populations is required.
introduction
Lipomatous tumours are common mesenchymal neoplasms of lipogenic differentiation and can be benign or malignant with a wide range of histological subtypes. 1, 2 Malignant liposarcomas necessitate wide excision with chemotherapy and/or radiotherapy, whereas benign lipomas can be treated with marginal excision or observation. 3, 4 Borderline, low-grade liposarcomas/atypical lipomatous tumours do not appear to metastasise but have an increased risk of local recurrence and a potential for dedifferentiation; these should be treated as malignant tumours.
The National Institute for Health and Care Excellence (NICE) guidelines recommend that any tumour deep to fascia, >5 cm, rapidly increasing in size, or painful in a previously painless lump should be regarded as malignant until proven otherwise. 5 Magnetic resonance imaging (MRI) can differentiate malignant from benign lipomatous tumours, [5] [6] [7] [8] particularly atypical lipomatous tumour/welldifferentiated liposarcoma from benign lipoma. [9] [10] [11] [12] Figure 1 Magnetic resonance imaging showing (a) a non-fatty nodule (≥1 cm) in a well-differentiated liposarcoma (asterisk), (b) a non-fatty septum (>2 mm) in a well-differentiated liposarcoma (arrow), and (c) internal cystic change in a myxoid liposarcoma.
(a) (b) (c)
This study aimed to construct a scoring system to differentiate malignant liposarcomas from benign lipomas by comparing their clinical and MRI features.
Materials and Methods
This study was approved by the ethics committee of our hospitals. Records of 33 women and 33 men aged 17 to 83 (mean, 53) years who underwent resection of malignant liposarcomas (n=32) or benign lipomas (n=34) from 2004 to 2012 were retrieved. Patients with recurrent lipomatous tumour or inadequate MRI were excluded. Histological diagnosis was made by consensus of 2 pathologists based on the World Health Organization criteria. 13 Clinical features were reviewed by an orthopaedic oncology surgeon, and MRI features were reviewed by a radiologist.
MRI features included the margin (well-defined vs. partially ill-defined/ill-defined), the homogeneity of signal intensity (homogeneous vs. inhomogeneous), bright signal intensity on T1-weighted fast spin echo images (entire lesion vs. partial/none), bright signal intensity on T2-weighted fast spin echo with fat suppression images (entire/partial lesion vs. none), non-fatty septum or nodule (no/thin vs. thick nonfatty septum [>2 mm] or nodule [>1cm]), internal cystic change (yes vs. no), non-fatty content (>50% vs. ≤50%), no fat signal (yes vs. no) [ Fig. 1 ].
Patients with liposarcoma were compared with those with lipoma using the unpaired Student's t test for normally distributed continuous variables, or the Fisher's exact test for categorical variables. A p value of <0.05 was considered statistically significant. In a univariate analysis, significant variables (p<0.1) were entered into a multiple logistic regression model using a backward selection method to determine the independent predictors. An odds ratios of >1 and <1 indicated an increased and decreased odds of liposarcoma, respectively.
The strongest predictors were chosen to construct the scoring system. The weighting of the predictors was determined by the coefficient (B) as: Z score=B 1 X 1 +…+B k X k . Before that, the discriminating power of the chosen score model was estimated and a receiver operating characteristic (ROC) curve was plotted. The ROC curve indicated the relationship of sensitivity and specificity (i.e. the cut-off score for differentiating malignant from benign lipomatous tumours). An area under the curve (AUC) of 1.0 indicated a perfect discrimination, whereas an AUC of 0.5 indicated no discrimination.
14 Another ROC curve was plotted to determine the cut-off for tumour size with maximum sensitivity and specificity using the Youden index 15 (i.e. sensitivity+specificity-1).
results
Of the 32 liposarcomas, 16 were atypical lipomatous tumours/well-differentiated liposarcomas, 10 were myxoid cell liposarcomas, one was pleomorphic liposarcoma, one was dedifferentiated liposarcoma, and 4 were mixed-type liposarcomas (3 pleomorphic/ myxoid and one well-differentiated/myxoid liposarcomas Patients with liposarcoma differed to those with lipoma in terms of gender, tumour depth, tumour maximum dimension, homogeneity of signal intensity, bright signal intensity on T1-weighted fast spin echo images, bright signal intensity on T2-weighted fast spin echo with fat suppression images, non-fatty septum or nodule, internal cystic change, and no fat signal ( Table 1 ). The 5 strongest predictors of liposarcoma were male gender, larger tumour maximum dimension, deep to fascia, thick non-fatty septum or nodule, and internal cystic change. They were entered in a multiple logistic regression analysis ( Table 2) for construction of a weighted scoring system to exclude malignant lipomatous tumours.
An ROC curve was plotted to determine the sensitivity and specificity of the scoring system. The AUC was 0.980 indicating strong power for the scoring system to discriminate malignant from benign lipomatous tumours (Fig. 2) . Another ROC curve was plotted to determine the sensitivity and specificity of tumour maximum dimension. The maximum Youden index was 0.669 with sensitivity of 0.875 and specificity of 0.794, and its corresponding tumour maximum dimension was 10.02 cm (Fig. 3) . A cut-off of 10 cm was used, but the tumour maximum dimension as a continuous variable was found to be more accurate.
The scoring system was constructed using the 5 strongest predictors as: Z score=2.40X 1 +0.33X 2 + 3.90X 3 +4.87X 4 +3.63X 5 , where X 1 denotes gender (1=male / 0=female), X 2 tumour maximum dimension in cm, X 3 tumour depth (1=deep to fascia / 0=subcutaneous), X 4 non-fatty septum or nodule (1=thick septum [>2 mm] or nodule [≥1 cm] / 0=no or thin), and X 5 internal cystic change (1=yes / 0=no). The coefficients were modified to be integerfriendly and weighting was added to corresponding predictors without changing the diagnosis outcome as: Z score=10X 1 +X 2 +12X 3 +15X 4 +10X 5 . The weighted score of all tumours was plotted and a cut-off score of 35 was used; all 32 malignant lipomatous tumours and 4 of 34 benign lipomatous tumours scored >35 (Fig. 4) . The cut-off score of ≤35 could predict 30 of 66 lipomatous tumours as benign with a negative predictive value of 100% (p<0.0001).
discussion
To plan the appropriate resection (marginal or wide), a biopsy should be performed to establish the diagnosis. Nonetheless, biopsy is time-and resourceconsuming and may generate anxiety. The biopsied tissue may be non-representative and the result may be false positive or negative. If a diagnosis can be made based on clinical and imaging findings, a Figure 2 A receiver operating characteristic curve is plotted to determine the sensitivity and specificity of the scoring system to differentiate malignant from benign lipomatous tumour. The area under the curve (AUC) of 0.980 indicates strong discriminating power. biopsy is not required. Many studies have reported correlation between imaging findings and pathological diagnosis. 1, 3, 4, 7, 8, 10, 11, 16 In our study, the tumour maximum dimension rather than multiple dimensions or total volume was used; its contribution to the scoring system was weak compared with other variables, although the NICE guideline recommends that a tumour of >5 cm should be regarded as malignant until proven otherwise. In our study using the Youden index, a cut-off for tumour size of 10 cm resulted in a slightly lower sensitivity and much high specificity for malignancy. 17, 18 Tumour size was more accurate as a continuous variable than as a categorical variable.
Many MRI features are related to each other. A lesion with homogenous signal intensity throughout does not have a thick septum or nodule. Our primary aim was to exclude malignancy; the scoring system should identify as many benign tumours as possible (high specificity) with a low false negative rate (high negative predictive value). Sensitivity was a secondary concern as the scoring system is intended to rule out rather than rule in malignancy. The absence of a nonfatty septum or nodule and internal cystic change had the highest specificity for benign tumour and good negative predictive value while maintaining reasonable sensitivity. Inhomogeneous signal intensity and the absence of bright signal intensity on T1-weighted fast spin echo images had the highest sensitivity for liposarcoma, but their specificity and negative predictive values were inferior to those of a thick septum or nodule and cystic degeneration.
Z score
Thick non-fatty septum or nodule was present in the myxoid, pleomorphic, dedifferentiated, and mixed-type liposarcomas. This feature was also present in 9 of 34 benign lipomas in our study, as the lipomas may contain areas of fat necrosis or fibrosis. 10 Internal cystic change is a typical feature of myxoid liposarcoma; nonetheless benign angiolipoma may also display the similar feature.
In a study of a scoring system to differentiate lipomas from atypical lipomatous tumours based on tumour diameter, depth, MRI septa, and MRI enhancement, 12 the sample size of 12 atypical lipomatous tumours and 48 lipomas was too small to allow multivariate analysis or weighting. No factor was significant in the univariate analysis. In a study of an algorithm for general surgeons to decide when to refer a patient with lipomatous tumour to a specialist, 19 factors included were patient age ≥55 years, tumour size ≥10 cm, extremity location, and previous resection; MRI features were not taken into account. Limitations of our study were its retrospective nature and inclusion of a single ethnic population.
conclusion
The 5 strongest clinical and MRI features were identified to construct a scoring system to differentiate malignant from benign lipomatous tumours. Further validation in independent populations is required.
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